Tristel plc (AIM:TSTL)

Market Cap	191.40M
Revenue (ttm)	46.46M
Net Income (ttm)	6.64M
Shares Out	47.85M
EPS (ttm)	0.14
PE Ratio	28.92
Forward PE	23.19
Dividend	0.14 (3.59%)
Ex-Dividend Date	Nov 27, 2025

Volume	175,707
Average Volume	87,159
Open	400.00
Previous Close	400.00
Day's Range	395.00 - 395.00
52-Week Range	260.00 - 445.00
Beta	0.23
RSI	46.50
Earnings Date	Feb 24, 2026

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 267
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.